Articles Tagged With:
-
Zilucoplan for Myasthenia Gravis
Zilucoplan, a macrocyclic peptide that binds complement component C5, showed promise as an effective agent for treatment of generalized myasthenia gravis in a Phase II trial.
-
Special Report from the 2020 International Stroke Conference, Los Angeles
These reviews of studies presented at the 2020 International Stroke Conference were written by Neurology Alert's editor after personal attendance at the presentations, followed by review of the simultaneous publications in Stroke. All comments and opinions are solely those of the editor.
-
Federal Agencies, Pharma Industry Work to Speed COVID-19 Therapeutics, Vaccine
Public-private partnership aims to streamline, coordinate large-scale efforts.
-
The Role of Surgeons in the COVID-19 Era
Accrediting body helps surgery leaders find the right path forward during unusual times.
-
Hypertensive Pregnancy Disorders May Negatively Affect Children’s Psychological Development
A recently published paper revealed certain health problems during pregnancy can lead to emotional and behavioral disorders in children.
-
Understanding Medical Marijuana
This article will evaluate and assess medical marijuana, also called medical cannabis, and will cover benefits and risks, clinical considerations affecting its recommendation, and currently available evidence.
-
Infectious Disease Alert Updates
Masking Our Anxiety; Is it Luck or Genetics? Neurologic Infection from SARS-CoV-2
-
Evaluation of 2020 Vancomycin Guidelines: Highlights, Limitations, and Obstacles
The key change from the 2009 vancomycin guidelines is the switch from trough-based to area under the curve (AUC)-based dosing and monitoring. This article will highlight key differences between the 2009 and 2020 guidelines, limitations of the new guidelines, and implementation issues.
-
Differentiating Clostridioides difficile Infection from Chronic Carriage in Patients with Diarrhea Through Host Inflammatory Markers
Investigators compared levels of inflammatory markers in patients with Clostridioides difficile infection (CDI) to those who were colonized with it. Several markers appeared to be able to distinguish true CDI, although a gold standard definition of CDI is needed.
-
Malaria Prophylaxis During Pregnancy
In a retrospective study of American military women involving 50 treated with atovaquone-proguanil and 156 exposed to mefloquine, no increase in risk of fetal loss or adverse infant outcomes was identified. Atovaquone-proguanil seems safe for use in pregnancy, but data are limited.